Skip to Main Content

2,429

Views

0

CrossRef citations to date

0

Altmetric

Coronavirus

SCB-2019 protein vaccine as heterologous booster of neutralizing activity against SARS-CoV-2 Omicron variants after immunization with other COVID-19 vaccines

Camilo C. Roa Jr.a Department of Physiology, Philippine General Hospital, University of the Philippines, Manila, PhilippinesView further author information

,

Mari Rose A. de Los Reyesb Local Clinics, Las Pinas Doctors Hospital, Las Pinas City, PhilippinesView further author information

,

Eric Plennevauxc Clinical Development, Clover Biopharmaceuticals, Cambridge, UKView further author information

,

Igor Smolenovd Clinical Development, Clover Biopharmaceuticals, Boston, MA, USAView further author information

,

Branda Hud Clinical Development, Clover Biopharmaceuticals, Boston, MA, USAView further author information

,

Faith Gaod Clinical Development, Clover Biopharmaceuticals, Boston, MA, USAView further author information

,

Hannalyn Ilagand Clinical Development, Clover Biopharmaceuticals, Boston, MA, USAView further author information

,

Donna Ambrosinoe Independent Advisor, Stuart, FL, USAView further author information

,

George Siberf Independent Advisor, New York, NY, USAView further author information

,

Ralf Clemensg Global Research in Infectious Diseases, Rio de Janeiro, BrazilView further author information

&

Htay Htay Hand Clinical Development, Clover Biopharmaceuticals, Boston, MA, USACorrespondence[email protected]
View further author information